Special Issue "Advances in Stem Cells and Regenerative Medicine"
Deadline for manuscript submissions: 15 September 2019
Regenerative medicine is a diverse and rapidly evolving field focused on enhancing the body’s ability to regenerate healthy tissue and overcome disease processes. Regenerative medicine is an interdisclinary approach employing core expertise from developmental biologists, stem cell biologists, clinicians, experts in chemistry and the physical sciences, engineers and imaging experts. The broad approaches of regenerative medicine are: (i) to understand the intrinsic repair mechanisms within tissues to promote these to improve healthy regeneration and reduce pathological wound healing responses, such as excessive scarring, and (ii) develop cell therapies whereby exogenous cells and organoids can be transplanted into tissues to help repair the damaged tissue or organs. To mimic in vitro the dynamic environment of healthy and diseased human tissues and organs, 3D microengineering approaches have been developed. Organ-on-a-chip is a promising technology to construct organ-specific microenvironments, reconstituting tissue structures, tissue-tissue interactions and interfaces, and dynamic mechanical and biochemical stimuli found in specific organs, to direct cells to assemble into functional tissues.
The current Special Issue will accept original studies, reviews and technical reports in the field of stem cell biology and regenerative medicine, written by researchers active in the field. Studies on the function of stem cells in different tissues and organs, influence of the niche during aging, injury and regeneration will be welcomed. Moreover, contributions in the field of “organ-on-a-chip” techonology will be appreciated.
Prof. Laura Lasagni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tissue-specific stem cells
- regenerative medicine
- stem cell niche
- disease modeling